Depomed Inc (NASDAQ: DEPO) shares zoomed 8.8% to $19.60, amid word KKR & Co. is said to be interested in the company and would combine it with Arbor Pharmaceuticals, according to sources as reported by the New York Post on Friday. Depomed has set Wednesday as the deadline for final bids, the sources said. Share volume was 3.2 million, double its all-day average
